;

Achillion, Idenix could miss hep-C merger bonanza

BOSTON (MarketWatch) — Investors tantalized by a recent string of lucrative takeover offers for hepatitis C drug-developers shouldn

Posted by admin on April 19th, 2012 | No Comments Posted in Top Stocks
;

5-Star Stocks Poised to Pop – Teva

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool’s free investing community, generic-drug giant Teva Pharmaceutical Industries (Nasdaq: TEVA  ) has earned a coveted five-star ranking. With that in mind, let’s take a closer look at Teva’s business and see what CAPS investors are saying about the stock right now. [...]

Posted by admin on January 28th, 2012 | No Comments Posted in Best Stocks To Buy, Chinese Stocks, Top Stocks
;

4-Star Stocks Poised to Pop – GlaxoSmithKline

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool’s free investing community, drug giant GlaxoSmithKline (NYSE: GSK  ) has earned a respected four-star ranking. With that in mind, let’s take a closer look at Glaxo’s business and see what CAPS investors are saying about the stock right now. Glaxo facts [...]

Posted by admin on November 2nd, 2011 | No Comments Posted in Best Stocks, Best Stocks To Buy, Top Stocks To Buy